179 related articles for article (PubMed ID: 19434722)
41. Parent and patient perspectives on barriers to medication adherence in adolescent transplant recipients.
Simons LE; McCormick ML; Mee LL; Blount RL
Pediatr Transplant; 2009 May; 13(3):338-47. PubMed ID: 18433413
[TBL] [Abstract][Full Text] [Related]
42. Treatment adherence in paediatric inflammatory bowel disease: perceptions from adolescent patients and their families.
Hommel KA; Odell S; Sander E; Baldassano RN; Barg FK
Health Soc Care Community; 2011 Jan; 19(1):80-8. PubMed ID: 21143544
[TBL] [Abstract][Full Text] [Related]
43. Correlates of health-related quality of life in pediatric inflammatory bowel disease: a cumulative risk model approach.
Gumidyala AP; Greenley RN
J Pediatr Psychol; 2014; 39(1):55-64. PubMed ID: 24078784
[TBL] [Abstract][Full Text] [Related]
44. Longitudinal stability of specific barriers to medication adherence.
Lee JL; Eaton C; Gutiérrez-Colina AM; Devine K; Simons LE; Mee L; Blount RL
J Pediatr Psychol; 2014 Aug; 39(7):667-76. PubMed ID: 24824613
[TBL] [Abstract][Full Text] [Related]
45. Age and body satisfaction predict diet adherence in adolescents with Inflammatory Bowel Disease.
Vlahou CH; Cohen LL; Woods AM; Lewis JD; Gold BD
J Clin Psychol Med Settings; 2008 Dec; 15(4):278-86. PubMed ID: 19104984
[TBL] [Abstract][Full Text] [Related]
46. Modifiable factors associated with nonadherence to maintenance medication for inflammatory bowel disease.
Selinger CP; Eaden J; Jones DB; Katelaris P; Chapman G; McDonald C; Smith P; Lal S; Leong RW; McLaughlin J; Robinson A
Inflamm Bowel Dis; 2013 Sep; 19(10):2199-206. PubMed ID: 23899547
[TBL] [Abstract][Full Text] [Related]
47. Perspectives of paediatric and adult gastroenterologists on transfer and transition care of adolescents with inflammatory bowel disease.
Wright EK; Williams J; Andrews JM; Day AS; Gearry RB; Bampton P; Moore D; Lemberg D; Ravikumaran R; Wilson J; Lewindon P; Radford-Smith G; Rosenbaum J; Catto-Smith A; Desmond PV; Connell WR; Cameron D; Alex G; Bell SJ; De Cruz P
Intern Med J; 2014 May; 44(5):490-6. PubMed ID: 24589174
[TBL] [Abstract][Full Text] [Related]
48. Mother, father, and adolescent self-control and adherence in adolescents with Type 1 diabetes.
Lansing AH; Crochiere R; Cueto C; Wiebe DJ; Berg CA
J Fam Psychol; 2017 Jun; 31(4):495-503. PubMed ID: 28080079
[TBL] [Abstract][Full Text] [Related]
49. Covert dose reduction is a distinct type of medication non-adherence observed across all care settings in inflammatory bowel disease.
Mountifield R; Andrews JM; Mikocka-Walus A; Bampton P
J Crohns Colitis; 2014 Dec; 8(12):1723-9. PubMed ID: 25263934
[TBL] [Abstract][Full Text] [Related]
50. Relationship Between Patient Knowledge and Medication Adherence in Inflammatory Bowel Disease.
Berry AC; Dholaria K; Czul-Gurdian F; Forster E; Chittajallu V; Graff E; Avalos DJ; Mulekar MS; Wang B; Deshpande AR
Inflamm Bowel Dis; 2017 Jun; 23(6):E39-E40. PubMed ID: 28505053
[No Abstract] [Full Text] [Related]
51. A Micro-longitudinal Approach to Measuring Medication Adherence in Pediatric Inflammatory Bowel Diseases.
Plevinsky JM; Denson LA; Hellmann J; Minar P; Rosen MJ; Hommel KA
J Pediatr Gastroenterol Nutr; 2020 Sep; 71(3):366-370. PubMed ID: 32404759
[TBL] [Abstract][Full Text] [Related]
52. Identifying barriers to treatment adherence and related attitudinal patterns in adolescents with cystic fibrosis.
Dziuban EJ; Saab-Abazeed L; Chaudhry SR; Streetman DS; Nasr SZ
Pediatr Pulmonol; 2010 May; 45(5):450-8. PubMed ID: 20425852
[TBL] [Abstract][Full Text] [Related]
53. Adherence to subcutaneous biological therapies in patients with inflammatory rheumatic diseases and inflammatory bowel disease: a systematic review.
Nieto JC; Arajol C; Carmona L; Marras C; Cea-Calvo L
Immunotherapy; 2021 Apr; 13(5):433-458. PubMed ID: 33557600
[No Abstract] [Full Text] [Related]
54. Factors that modify therapy adherence in patients with inflammatory bowel disease.
Bermejo F; López-San Román A; Algaba A; Guerra I; Valer P; García-Garzón S; Piqueras B; Villa C; Bermejo A; Rodríguez-Agulló JL
J Crohns Colitis; 2010 Oct; 4(4):422-6. PubMed ID: 21122538
[TBL] [Abstract][Full Text] [Related]
55. Clinical impact and drivers of non-adherence to maintenance medication for inflammatory bowel disease.
Selinger CP; Robinson A; Leong RW
Expert Opin Drug Saf; 2011 Nov; 10(6):863-70. PubMed ID: 21548837
[TBL] [Abstract][Full Text] [Related]
56. Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence.
Trindade AJ; Ehrlich A; Kornbluth A; Ullman TA
Inflamm Bowel Dis; 2011 Feb; 17(2):599-604. PubMed ID: 20848512
[TBL] [Abstract][Full Text] [Related]
57. Clinical cutoffs for adherence barriers in solid organ transplant recipients: how many is too many?
Eaton CK; Lee JL; Simons LE; Devine KA; Mee LL; Blount RL
J Pediatr Psychol; 2015 May; 40(4):431-41. PubMed ID: 25418331
[TBL] [Abstract][Full Text] [Related]
58. Adherence to medical treatment in inflammatory bowel disease patients.
Zelante A; De Giorgi A; Borgoni R; Trevisani L; Gallerani M
Minerva Gastroenterol Dietol; 2014 Dec; 60(4):269-74. PubMed ID: 25384805
[TBL] [Abstract][Full Text] [Related]
59. Self-Reported Medication Adherence Barriers Among Ambulatory Older Adults with Mild Cognitive Impairment.
Campbell NL; Zhan J; Tu W; Weber Z; Ambeuhl R; McKay C; McElwee N
Pharmacotherapy; 2016 Feb; 36(2):196-202. PubMed ID: 26890914
[TBL] [Abstract][Full Text] [Related]
60. Young age and tobacco use are predictors of lower medication adherence in inflammatory bowel disease.
Bruna-Barranco I; Lué A; Gargallo-Puyuelo CJ; Arroyo MT; Alfambra E; Montero J; Gomollón F
Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):948-953. PubMed ID: 31107739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
